vs
科迪华(CTVA)与Legacy Housing Corp(LEGH)财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是Legacy Housing Corp的153.5倍($3.9B vs $25.5M)。Legacy Housing Corp净利率更高(32.2% vs -14.1%,领先46.3%)。科迪华同比增速更快(-1.7% vs -30.6%)。科迪华自由现金流更多($4.2B vs $15.7M)。过去两年科迪华的营收复合增速更高(-6.7% vs -9.1%)
科迪华是一家美国农业科技企业,主营种子与作物保护产品,涵盖除草剂、杀虫剂、杀菌剂及生物制剂,业务覆盖全球110个国家,总部位于印第安纳州印第安纳波利斯,旗下大部分种子产品以先锋良种国际品牌销售。
Legacy Housing Corp是美国知名的经济型预制住宅、微型住宅及配套居住单元制造商,主要面向北美中低收入消费群体,提供可定制住房解决方案、配套建材及相关售后服务,服务个人及社区开发类客户。
CTVA vs LEGH — 直观对比
营收规模更大
CTVA
是对方的153.5倍
$25.5M
营收增速更快
CTVA
高出28.9%
-30.6%
净利率更高
LEGH
高出46.3%
-14.1%
自由现金流更多
CTVA
多$4.1B
$15.7M
两年增速更快
CTVA
近两年复合增速
-9.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $3.9B | $25.5M |
| 净利润 | $-552.0M | $8.2M |
| 毛利率 | 42.4% | 26.4% |
| 营业利润率 | -13.6% | 40.4% |
| 净利率 | -14.1% | 32.2% |
| 营收同比 | -1.7% | -30.6% |
| 净利润同比 | -1246.3% | -43.5% |
| 每股收益(稀释后) | $-0.80 | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTVA
LEGH
| Q4 25 | $3.9B | $25.5M | ||
| Q3 25 | $2.6B | $28.8M | ||
| Q2 25 | $6.5B | $38.4M | ||
| Q1 25 | $4.4B | $24.3M | ||
| Q4 24 | $4.0B | $36.7M | ||
| Q3 24 | $2.3B | $30.2M | ||
| Q2 24 | $6.1B | $31.7M | ||
| Q1 24 | $4.5B | $30.8M |
净利润
CTVA
LEGH
| Q4 25 | $-552.0M | $8.2M | ||
| Q3 25 | $-320.0M | $8.6M | ||
| Q2 25 | $1.3B | $14.7M | ||
| Q1 25 | $652.0M | $10.3M | ||
| Q4 24 | $-41.0M | $14.5M | ||
| Q3 24 | $-524.0M | $15.8M | ||
| Q2 24 | $1.1B | $16.2M | ||
| Q1 24 | $419.0M | $15.1M |
毛利率
CTVA
LEGH
| Q4 25 | 42.4% | 26.4% | ||
| Q3 25 | 37.2% | 20.2% | ||
| Q2 25 | 54.6% | 32.4% | ||
| Q1 25 | 47.0% | 29.2% | ||
| Q4 24 | 37.3% | 27.3% | ||
| Q3 24 | 32.7% | 29.2% | ||
| Q2 24 | 52.3% | 31.9% | ||
| Q1 24 | 43.2% | 33.6% |
营业利润率
CTVA
LEGH
| Q4 25 | -13.6% | 40.4% | ||
| Q3 25 | -14.1% | 33.7% | ||
| Q2 25 | 27.9% | 43.8% | ||
| Q1 25 | 17.7% | 47.7% | ||
| Q4 24 | 2.2% | 42.3% | ||
| Q3 24 | -27.2% | 50.8% | ||
| Q2 24 | 21.9% | 50.6% | ||
| Q1 24 | 10.7% | 54.3% |
净利率
CTVA
LEGH
| Q4 25 | -14.1% | 32.2% | ||
| Q3 25 | -12.2% | 30.0% | ||
| Q2 25 | 20.4% | 38.3% | ||
| Q1 25 | 14.8% | 42.3% | ||
| Q4 24 | -1.0% | 39.5% | ||
| Q3 24 | -22.5% | 52.4% | ||
| Q2 24 | 17.2% | 51.1% | ||
| Q1 24 | 9.3% | 49.1% |
每股收益(稀释后)
CTVA
LEGH
| Q4 25 | $-0.80 | $0.38 | ||
| Q3 25 | $-0.47 | $0.35 | ||
| Q2 25 | $1.92 | $0.60 | ||
| Q1 25 | $0.95 | $0.41 | ||
| Q4 24 | $-0.05 | $0.59 | ||
| Q3 24 | $-0.76 | $0.64 | ||
| Q2 24 | $1.51 | $0.65 | ||
| Q1 24 | $0.60 | $0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $8.5M |
| 总债务越低越好 | $1.7B | — |
| 股东权益账面价值 | $24.1B | $528.6M |
| 总资产 | $42.8B | $580.3M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势,按日历期对齐
现金及短期投资
CTVA
LEGH
| Q4 25 | $4.5B | $8.5M | ||
| Q3 25 | $2.6B | $13.6M | ||
| Q2 25 | $2.1B | $2.6M | ||
| Q1 25 | $2.0B | $3.4M | ||
| Q4 24 | $3.2B | $1.1M | ||
| Q3 24 | $2.5B | $570.0K | ||
| Q2 24 | $2.0B | $60.0K | ||
| Q1 24 | $1.7B | $621.0K |
总债务
CTVA
LEGH
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.5B | — |
股东权益
CTVA
LEGH
| Q4 25 | $24.1B | $528.6M | ||
| Q3 25 | $25.2B | $521.6M | ||
| Q2 25 | $25.9B | $512.8M | ||
| Q1 25 | $24.3B | $503.7M | ||
| Q4 24 | $23.8B | $494.0M | ||
| Q3 24 | $24.7B | $479.3M | ||
| Q2 24 | $25.2B | $463.2M | ||
| Q1 24 | $24.8B | $450.4M |
总资产
CTVA
LEGH
| Q4 25 | $42.8B | $580.3M | ||
| Q3 25 | $42.2B | $557.9M | ||
| Q2 25 | $41.8B | $552.0M | ||
| Q1 25 | $42.1B | $544.6M | ||
| Q4 24 | $40.8B | $534.2M | ||
| Q3 24 | $41.9B | $521.4M | ||
| Q2 24 | $41.5B | $514.9M | ||
| Q1 24 | $43.6B | $510.0M |
负债/权益比
CTVA
LEGH
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | 0.08× | — | ||
| Q2 24 | 0.10× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.4B | $19.0M |
| 自由现金流经营现金流 - 资本支出 | $4.2B | $15.7M |
| 自由现金流率自由现金流/营收 | 106.2% | 61.6% |
| 资本支出强度资本支出/营收 | 5.7% | 13.1% |
| 现金转化率经营现金流/净利润 | — | 2.32× |
| 过去12个月自由现金流最近4个季度 | $2.8B | $28.2M |
8季度趋势,按日历期对齐
经营现金流
CTVA
LEGH
| Q4 25 | $4.4B | $19.0M | ||
| Q3 25 | $193.0M | $7.2M | ||
| Q2 25 | $947.0M | $6.1M | ||
| Q1 25 | $-2.1B | $4.9M | ||
| Q4 24 | $4.2B | $7.9M | ||
| Q3 24 | $130.0M | $13.8M | ||
| Q2 24 | $451.0M | $3.5M | ||
| Q1 24 | $-2.6B | $10.8M |
自由现金流
CTVA
LEGH
| Q4 25 | $4.2B | $15.7M | ||
| Q3 25 | $36.0M | $5.1M | ||
| Q2 25 | $829.0M | $3.7M | ||
| Q1 25 | $-2.2B | $3.6M | ||
| Q4 24 | $4.0B | $6.0M | ||
| Q3 24 | $-24.0M | $9.1M | ||
| Q2 24 | $337.0M | $1.7M | ||
| Q1 24 | $-2.8B | $9.9M |
自由现金流率
CTVA
LEGH
| Q4 25 | 106.2% | 61.6% | ||
| Q3 25 | 1.4% | 17.8% | ||
| Q2 25 | 12.8% | 9.6% | ||
| Q1 25 | -49.9% | 15.0% | ||
| Q4 24 | 100.4% | 16.4% | ||
| Q3 24 | -1.0% | 30.2% | ||
| Q2 24 | 5.5% | 5.4% | ||
| Q1 24 | -61.4% | 32.2% |
资本支出强度
CTVA
LEGH
| Q4 25 | 5.7% | 13.1% | ||
| Q3 25 | 6.0% | 7.1% | ||
| Q2 25 | 1.8% | 6.2% | ||
| Q1 25 | 2.1% | 5.2% | ||
| Q4 24 | 4.6% | 5.1% | ||
| Q3 24 | 6.6% | 15.6% | ||
| Q2 24 | 1.9% | 5.5% | ||
| Q1 24 | 3.3% | 2.8% |
现金转化率
CTVA
LEGH
| Q4 25 | — | 2.32× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | 0.72× | 0.41× | ||
| Q1 25 | -3.23× | 0.48× | ||
| Q4 24 | — | 0.54× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | 0.43× | 0.21× | ||
| Q1 24 | -6.23× | 0.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
LEGH
| Commercial Sales | $8.6M | 34% |
| Retail Store Sales | $6.0M | 24% |
| Inventory Finance Sales | $5.0M | 20% |
| Direct Sales | $4.4M | 17% |
| Other | $1.5M | 6% |